IPO registrations (S-1, F-1) · Registrants
T2 Biosystems, Inc.
- SEC CIK
- 1492674 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2014-07-02, last 2024-05-06; 2 initial registrations, 4 amendments
- Outcome
- Final prospectus filed 2014-08-07; declared effective 2014-08-06; withdrawal requested 2024-05-14
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 101 HARTWELL AVENUE, Lexington, MA 02421
- EIN
- 20-4827488
- EDGAR entity type
- operating
- Insiders and CEO pay
- T2 Biosystems, Inc. on the corporate pages
Offering terms
- Proposed price range
- $15.00–$17.00 per share (S-1/A filed 2014-07-28)
- Final price
- $11.00 per share, below the range (424B4 filed 2014-08-07, an initial public offering)
- Shares sold
- 5,200,000
- Gross proceeds
- $57,200,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol TTOO
- Lead underwriters
- Goldman Sachs (2,080,000 shares); Morgan Stanley (2,080,000 shares)
- Syndicate
- Leerink Partners (728,000); Janney Montgomery Scott (312,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: T2 BIOSYSTEMS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: T2 Biosystems, Inc Fuzzy (name and state)
- Business registration: T2 Biosystems, Inc. Fuzzy (name and state)
- Business registration: T2 Biosystems, Inc. Fuzzy (name and state)
- Business registration: T2 BIOSYSTEMS, INC. Fuzzy (name and state)
- Business registration: T2 BIOSYSTEMS, INC. Fuzzy (name and state)
- Business registration: T2 BIOSYSTEMS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: T2 BIOSYSTEMS, INC EXACT (EIN (EXACT))
- Federal award recipient: T2 BIOSYSTEMS, INC Fuzzy (name and state)
- Form D issuer: T2 Biosystems, Inc. EXACT (CIK (EXACT))
- Lobbying client: T2 BIOSYSTEMS Fuzzy (name and state)
- Lobbying client: T2 BIOSYSTEMS, INC. Fuzzy (name and state)
- SEC filer: T2 Biosystems, Inc. EXACT (CIK (EXACT))
- Person page: Adrian M Jones Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: David B Elsbree Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: John W Cumming Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 17
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-07-02 | S-1 | S-1 (registration) | T2 Biosystems, Inc. | 0001047469-14-005988 ↗ |
| 2014-07-16 | S-1/A | S-1/A (amendment) | T2 Biosystems, Inc. | 0001047469-14-006215 ↗ |
| 2014-07-28 | S-1/A | S-1/A (amendment) | T2 Biosystems, Inc. | 0001047469-14-006416 ↗ |
| 2014-08-06 | S-1MEF | S-1MEF (added securities) | T2 Biosystems, Inc. | 0001104659-14-057771 ↗ |
| 2014-08-06 | EFFECT | EFFECT (declared effective) | T2 Biosystems, Inc. | 9999999995-14-002407 ↗ |
| 2014-08-07 | 424B4 | 424B4 (final prospectus) | T2 Biosystems, Inc. | 0001047469-14-006761 ↗ |
| 2015-09-22 | EFFECT | EFFECT (declared effective) | T2 Biosystems, Inc. | 9999999995-15-002566 ↗ |
| 2017-05-05 | EFFECT | EFFECT (declared effective) | T2 Biosystems, Inc. | 9999999995-17-001197 ↗ |
| 2018-10-24 | EFFECT | EFFECT (declared effective) | T2 Biosystems, Inc. | 9999999995-18-002710 ↗ |
| 2021-04-09 | EFFECT | EFFECT (declared effective) | T2 Biosystems, Inc. | 9999999995-21-001381 ↗ |
| 2023-09-15 | EFFECT | EFFECT (declared effective) | T2 Biosystems, Inc. | 9999999995-23-002675 ↗ |
| 2024-04-22 | S-1 | S-1 (registration) | T2 Biosystems, Inc. | 0001193125-24-105041 ↗ |
| 2024-05-06 | S-1/A | S-1/A (amendment) | T2 Biosystems, Inc. | 0001193125-24-131474 ↗ |
| 2024-05-06 | S-1/A | S-1/A (amendment) | T2 Biosystems, Inc. | 0001193125-24-132063 ↗ |
| 2024-05-14 | RW | RW (withdrawal request) | T2 Biosystems, Inc. | 0001193125-24-138338 ↗ |
| 2024-06-04 | EFFECT | EFFECT (declared effective) | T2 Biosystems, Inc. | 9999999995-24-001744 ↗ |
| 2024-07-29 | EFFECT | EFFECT (declared effective) | T2 Biosystems, Inc. | 9999999995-24-002305 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-07-28 | S-1/A | registration statement | $15.00–$17.00 | 4,000,000 | - | Nasdaq TTOO | 4 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4 | document ↗ | |
| 2014-08-07 | 424B4 | final prospectus | $11.00 | 5,200,000 | $57,200,000 | Nasdaq TTOO | 4 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| AFEYAN NOUBAR | TenPercentOwner | 2 | 2014 | ||
| AISLING CAPITAL III LP | TenPercentOwner | 3 | 2014–2015 | ||
| Aisling Capital Partners III LLC | TenPercentOwner | 3 | 2014–2015 | ||
| Aisling Capital Partners III LP | TenPercentOwner | 3 | 2014–2015 | ||
| Bilenker Joshua H. | Director | 3 | 2014–2016 | ||
| Bridge Street 2013 Holdings, L.P. | TenPercentOwner | 3 | 2014–2015 | ||
| Bridge Street 2013, L.P. | TenPercentOwner | 3 | 2014–2015 | ||
| Bridge Street 2013 Offshore, L.P. | TenPercentOwner | 3 | 2014–2015 | ||
| Bridge Street Opportunity Advisors, L.L.C. | TenPercentOwner | 3 | 2014–2015 | ||
| Broad Street Principal Investments, L.L.C. | TenPercentOwner | 3 | 2014–2015 | ||
| CARELLA THOMAS J. | Director | 4 | 2014–2015 | ||
| Cima Michael J. | Director | 13 | 2014–2019 | ||
| Crane Alan L | Director | 2 | 2014 | ||
| CUMMING JOHN W | Director | 15 | 2014–2025 | person page Fuzzy | |
| ELMS STEVE | Director,TenPercentOwner; TenPercentOwner | 3 | 2014–2015 | ||
| Elsbree David B | Director | 30 | 2014–2025 | person page Fuzzy | |
| Flagship Ventures Fund 2004 L P | TenPercentOwner | 2 | 2014 | ||
| Flagship Ventures Fund IV General Partner LLC | TenPercentOwner | 2 | 2014 | ||
| Flagship Ventures Fund IV, L.P. | TenPercentOwner | 2 | 2014 | ||
| Flagship Ventures General Partner LLC | TenPercentOwner | 2 | 2014 | ||
| GOLDMAN SACHS & CO | TenPercentOwner | 10 | 2014–2021 | ||
| GOLDMAN SACHS GROUP INC | TenPercentOwner | 10 | 2014–2021 | ||
| Jones Marc R. | Officer | Chief Financial Officer | 1 | 2014 | |
| Kalil Sarah O. | Officer | Chief Operating Officer | 6 | 2014–2016 | |
| KANIA EDWIN M JR | TenPercentOwner | 2 | 2014 | ||
| LAPIDUS STANLEY N | Director | 2 | 2014–2015 | ||
| Lowery Thomas J. | Officer | Chief Scientific Officer | 30 | 2014–2020 | |
| MBD 2013 Holdings, L.P. | TenPercentOwner | 3 | 2014–2015 | ||
| MBD 2013, L.P. | TenPercentOwner | 3 | 2014–2015 | ||
| MBD 2013 Offshore, L.P. | TenPercentOwner | 3 | 2014–2015 | ||
| MBD Advisors, L.L.C. | TenPercentOwner | 3 | 2014–2015 | ||
| McDonough John | Director; Director,Officer | President and CEO; President & CEO | 21 | 2014–2021 | |
| Pfaller Michael A. | Officer | Chief Medical Officer | 3 | 2014–2016 | |
| Polaris Venture Management Co. V, L.L.C. | TenPercentOwner | 12 | 2014–2015 | ||
| Polaris Venture Partners Entrepreneurs' Fund V, L.P. | TenPercentOwner | 12 | 2014–2015 | ||
| Polaris Venture Partners Founders' Fund V, L.P. | TenPercentOwner | 12 | 2014–2015 | ||
| Polaris Venture Partners Special Founders' Fund V, L.P. | TenPercentOwner | 12 | 2014–2015 | ||
| Polaris Venture Partners V, L.P. | TenPercentOwner | 12 | 2014–2015 | ||
| Purcell Dennis J | TenPercentOwner | 3 | 2014–2015 | ||
| SCHIFF ANDREW N | TenPercentOwner | 3 | 2014–2015 | ||
| WILCOX HARRY W | Director | 3 | 2014–2016 | ||
| CASTONGUAY MAURICE L | Officer | Chief Financial Officer | 2 | 2015 | |
| Harding David | Officer | Chief Commercial Officer | 3 | 2015–2017 | |
| Gibbs Michael Terrence | Officer | General Counsel | 34 | 2016–2025 | |
| Dhanda Rahul | Officer | SVP of Corporate Development | 8 | 2016–2017 | |
| Jones Adrian M | Director | 9 | 2016–2021 | person page Fuzzy | |
| Lynch Shawn | Officer | Chief Financial Officer | 3 | 2016–2017 | |
| Lapidus Stanley | Director | 8 | 2016–2019 | ||
| Spadoro Joanne | Officer | Chief Operations Officer | 4 | 2016–2017 | |
| LIEBMAN SEYMOUR | Director | 17 | 2016–2025 | ||
| CANON INC | TenPercentOwner | 1 | 2016 | ||
| CANON U.S.A., INC. | TenPercentOwner | 1 | 2016 | ||
| DEPTULA-HICKS DARLENE M | Officer | Chief Financial Officer; SVP & Chief Financial Officer | 3 | 2017 | |
| Sprague John M | Officer | CFO; Chief Financial Officer | 19 | 2018–2025 | |
| Barclay Alec | Officer | Chief Operations Officer; See Remarks; SVP, Operations | 18 | 2018–2022 | |
| Sperzel John J III | Director,Officer | Chairman and CEO; Chairman, CEO, and President; President and CEO; See Remarks | 10 | 2020–2025 | |
| Pare Anthony | Officer | Chief Commercial Officer | 5 | 2020–2021 | |
| Bernard Thierry | Director | 11 | 2020–2023 | ||
| Saunders Ninfa | Director | 12 | 2020–2025 | ||
| Toft Robin | Director | 13 | 2020–2025 | ||
| Ahuja Aparna | Officer | Chief Medical Officer | 5 | 2021–2022 | |
| Adams Laura Lee | Director | 6 | 2021–2025 | ||
| Giffin Brett A. | Officer | Chief Commercial Officer | 11 | 2021–2025 | |
| CRG Partners III (Cayman) Lev AIV I L.P. | TenPercentOwner | 14 | 2023–2024 | ||
| CRG Partners III (Cayman) Unlev AIV I L.P. | TenPercentOwner | 14 | 2023–2024 | ||
| CRG Partners III L.P. | TenPercentOwner | 14 | 2023–2024 | ||
| CRG Partners III - Parallel Fund (A) L.P. | TenPercentOwner | 14 | 2023–2024 | ||
| CR Group L.P. | TenPercentOwner | 14 | 2023–2024 | ||
| CRG Partners III - Parallel Fund B (Cayman) L.P. | TenPercentOwner | 5 | 2023–2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2016-09-27 | T2 Biosystems, Inc. | Other Health Care | $39,723,037 | $39,723,037 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | T2 Biosystems, Inc | MA | State business registries | name and state |
| Business registration | T2 Biosystems, Inc. | MA | State business registries | name and state |
| Business registration | T2 Biosystems, Inc. | MA | State business registries | name and state |
| Business registration | T2 BIOSYSTEMS, INC. | MA | State business registries | name and state |
| Business registration | T2 BIOSYSTEMS, INC. | MA | State business registries | name and state |
| Business registration | T2 BIOSYSTEMS, INC. | MA | State business registries | name and state |
| Business registration | T2 BIOSYSTEMS, INC. | MA | State business registries | name and state |
| Plan sponsor | T2 BIOSYSTEMS | MA | Form 5500 (employee benefit plans) | name and state |
| Plan sponsor | T2 BIOSYSTEMS, INC | MA | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | T2 BIOSYSTEMS, INC | MA | Federal spending (USAspending) | name and state |
| Form D issuer | T2 Biosystems, Inc. | MA | Form D private offerings | CIK (EXACT) |
| Lobbying client | T2 BIOSYSTEMS | MA | Federal lobbying (LDA) | name and state |
| Lobbying client | T2 BIOSYSTEMS, INC. | MA | Federal lobbying (LDA) | name and state |
| Paying company | T2 Biosystems, Inc. | MA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | T2 Biosystems, Inc. | MA | Patents (USPTO) | name and state |
| SEC filer | T2 Biosystems, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | T2 Biosystems, Inc. | MA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | T2 BIOSYSTEMS, INC | EIN (EXACT) | ||
| Person page | Adrian M Jones | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | David B Elsbree | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | John W Cumming | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, MA first:
- NMT MEDICAL INC MA
- ARBIOS SYSTEMS INC MA
- INSULET CORP MA
- LEMAITRE VASCULAR INC MA
- BIOVENTRIX, INC. MA
- NeuroMetrix, Inc. MA
- INVIVO THERAPEUTICS HOLDINGS CORP. MA
- ACCELLENT LLC MA
- Lyra Therapeutics, Inc. MA
- Corindus Vascular Robotics, Inc. MA
In other datasets, the same topic (Technology) in MA:
- Form D issuer: 10 Percent Happier, Inc. (Form D private offerings)
- Lobbying client: 5G ACTION NOW (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology